AbbVie 2Q Revenues: $8.3 billion (+19%) 2Q Earnings: $2.0 billion (+4%) YTD Revenues: $10.5 billion (+25%) YTD Earnings: $4.8 billion (+31%) Comments: HUMIRA sales increased 10% to $5.2 billion in the quarter. IMBRUVICA sales were $850 million, up 36%. Global HCV revenues were $973 million, up more than 100%. Creon sales were up 11% to $219 million. Lupron sales were $223 million, up 6%. Synthroid sales were flat at $193 million. AndroGel sales declined 17% to $128 million. Duodopa sales we...